The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide. Tocilizumab has shown promising results in retrospective studies in patients with COVID-19 pneumonia with a good safety profile.
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial / Salvarani, Carlo; Dolci, Giovanni; Massari, Marco; Merlo, Domenico Franco; Cavuto, Silvio; Savoldi, Luisa; Bruzzi, Paolo; Boni, Fabrizio; Braglia, Luca; Turrà, Caterina; Ballerini, Pier Ferruccio; Sciascia, Roberto; Zammarchi, Lorenzo; Para, Ombretta; Scotton, Pier Giorgio; Inojosa, Walter Omar; Ravagnani, Viviana; Salerno, Nicola Duccio; Sainaghi, Pier Paolo; Brignone, Alessandro; Codeluppi, Mauro; Teopompi, Elisabetta; Milesi, Maurizio; Bertomoro, Perla; Claudio, Norbiato; Salio, Mario; Falcone, Marco; Cenderello, Giovanni; Donghi, Lorenzo; Del Bono, Valerio; Colombelli, Paolo Luigi; Angheben, Andrea; Passaro, Angelina; Secondo, Giovanni; Pascale, Renato; Piazza, Ilaria; Facciolongo, Nicola; Costantini, Massimo. - In: JAMA INTERNAL MEDICINE. - ISSN 2168-6106. - ELETTRONICO. - (2021), pp. 1-1. [10.1001/jamainternmed.2020.6615]
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
Cavuto, Silvio;Zammarchi, Lorenzo;Para, Ombretta;
2021
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide. Tocilizumab has shown promising results in retrospective studies in patients with COVID-19 pneumonia with a good safety profile.
| File | Dimensione | Formato | |
|---|---|---|---|
|
jamainternal_salvarani_2020_oi_200094_1609365347.37772.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Solo lettura
Dimensione
484.68 kB
Formato
Adobe PDF
|
484.68 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
